title: Identification of intracellular sites of superoxide production in stimulated neutrophils.
abstract: In this study, we show that superoxide production is carried out within intracellular compartments of human neutrophils and not at the plasma membrane following stimulation with phorbol myristate acetate. Oxidant production was not observed in unstimulated cells. Stimulated cells exhibited superoxide production in two distinct types of intracellular organelles. Initially, activity was detected in slender rod-shaped granules and in spherical or elliptical granules. The oxidant-producing granules fused directly with the plasma membrane or fused to form larger intracellular vesicles which then became associated with the plasma membrane. Longer periods of stimulation with PMA resulted in a decrease in the number of vesicles containing oxidant reaction product only, and an increase in structures containing both the oxidant-reaction product and ferritin particles; the latter was used herein as a marker for endocytosis. Thus a complex pattern of intracellular vesicular trafficking occurs in stimulated neutrophils. Alkaline phosphatase activity, a marker enzyme for a type of intracellular neutrophil granule was co-localized in the oxidant reaction-positive intracellular compartments. The time course of up-regulation of alkaline phosphatase activity to the cell surface parallelled the release of superoxide from stimulated cells. Results from this study demonstrate for the first time cytochemical and morphological evidence that superoxide is released from stimulated neutrophils through exocytosis of an oxidant-producing intracellular granule.
authors.affiliation: Department of Anatomy, Kochi Medical School, Kochi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: J M
authors.initials: JM
authors.lastname: Robinson
authors.forename: H
authors.initials: H
authors.lastname: Seguchi
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D002273:Carcinogens / Q000494:pharmacology; D002563:Cerium / Q000378:metabolism; D004396:Coloring Agents; D003594:Cytoplasmic Granules / Q000201:enzymology / Q000648:ultrastructure; D005089:Exocytosis / Q000502:physiology; D005293:Ferritins / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008345:Manganese / Q000494:pharmacology; D008854:Microscopy, Electron; D019255:NADPH Oxidases / Q000378:metabolism; D018375:Neutrophil Activation / Q000187:drug effects / Q000502:physiology*; D009504:Neutrophils / Q000166:cytology / Q000201:enzymology* / Q000648:ultrastructure; D016877:Oxidants / Q000378:metabolism; D012430:Ruthenium Red; D013482:Superoxide Dismutase / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D004124:p-Dimethylaminoazobenzene
chemical_list: D002273:Carcinogens; D004396:Coloring Agents; D016877:Oxidants; D013481:Superoxides; D012430:Ruthenium Red; D002563:Cerium; D008345:Manganese; D005293:Ferritins; D004124:p-Dimethylaminoazobenzene; D013482:Superoxide Dismutase; D019255:NADPH Oxidases; D000469:Alkaline Phosphatase; D013755:Tetradecanoylphorbol Acetate